FDA property auction: DG Muhammad Asif Chaudhry directs absolute transparency and merit for upcoming auction on Oct 15

Faisalabad 8 Oct (DIGITAL ITLA): Director General Faisalabad Development Authority (FDA) Muhammad Asif Chaudhry has issued strict directives to ensure that the upcoming auction of commercial plots, shops, and properties, scheduled for Thursday, October 15, is conducted with complete transparency, organization, and adherence to merit. He emphasized that the auction proceedings will be closely monitored by a dedicated auction committee, ensuring all regulatory frameworks are strictly followed. Additional Director General FDA Qaiser Abbas Rand was also present during the review meeting.

During the briefing, Director Estate Management-I Junaid Hassan Manj briefed the DG on the selected properties, their locations, dimensions, expected valuation, and auction terms. He informed that the auction will feature 99 neighborhood shops and 46 commercial center shops in Ahmad Nagar, 23 neighborhood shops and 13 commercial center shops in Millat Town Block A, alongside 2 shops in Allama Iqbal Colony Block C. Furthermore, a commercial plot measuring approximately 14 marlas in 212 Sir Syed Town III and a 4-marla commercial plot (No. 27) in Madina Town Extension will be put up for sale.

The briefing highlighted that two major plots measuring 9.43 kanals and 3.2 kanals adjacent to the Hockey Stadium will be auctioned on a 19-year lease, while shops on various floors of Gulistan Plaza, Millat Road, will be offered on rent. Additionally, plots reserved for educational and healthcare facilities across 110 private housing schemes and 16 FDA-controlled residential colonies will be included in the public auction to promote essential civic amenities.

Detailing the outreach efforts, it was shared that extensive publicity campaigns, including streamers on major avenues and prominent billboards, have been executed to engage prospective buyers and investors. DG Muhammad Asif Chaudhry instructed officials to provide transparent guidance to all participants regarding rules, conditions, and property details, warning that zero deviations from regulations will be tolerated. He concluded by stating that utilizing FDA's assets efficiently to boost institutional revenue is a key objective, making absolute transparency and fairness non-negotiable.